![Jason M. Walsh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason M. Walsh
Fondateur chez Provenance Biopharmaceuticals Corp.
Postes actifs de Jason M. Walsh
Sociétés | Poste | Début | Fin |
---|---|---|---|
Provenance Biopharmaceuticals Corp.
![]() Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Fondateur | 01/01/2008 | - |
Corporate Officer/Principal | - | - | |
Bioscience Network, Inc. | President | 26/10/2010 | - |
Historique de carrière de Jason M. Walsh
Anciens postes connus de Jason M. Walsh
Sociétés | Poste | Début | Fin |
---|---|---|---|
MERCK KGAA | Corporate Officer/Principal | - | - |
Lexigen Pharmaceuticals Corp.
![]() Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Directeur Financier/CFO | - | - |
Formation de Jason M. Walsh
University of Massachusetts | Undergraduate Degree |
Babson College | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Allemagne | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Founder | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MERCK KGAA | Health Technology |
Entreprise privées | 3 |
---|---|
Provenance Biopharmaceuticals Corp.
![]() Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Health Technology |
Lexigen Pharmaceuticals Corp.
![]() Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
Bioscience Network, Inc. |
- Bourse
- Insiders
- Jason M. Walsh
- Expérience